Positions

Associate Professor of Medicine in the School of Medicine

2021 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2011 School of Medicine

Education

M.D., Tulane University 2004

2004 Tulane University

residency, Tulane University, MEDICINE 2004 - 2007

2007 Tulane University

Clinical Trials

A031801: Advanced Renal Cell Carcinoma with Bone Metastasis

Astellas: Intramuscular abiraterone decanoate for metastatic prostate cancer

M20-431: ABBV-CLS-484 +/- immunotherapy or VEGF TKI

ODYSSEY Registry for Renal Cell Carcinoma

Publications, Grants & Awards

• Grants (33)
• Academics Articles (106)
• Conference Pages (77)
• Book Sections (3)

Showing 1 - 5 of 33

A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (KEYMAKER-U03): Substudy 03C in Participants With Recurrent Disease During or After Anti-PD-(L)1 Adjuvant Therapy

2025-2030Merck Sharp & Dohme

A Phase I/IIa theranostic study of 64Cu-SAR-BBN and 67CuSAR-BBN for identification and treatment of RPRexpressing metastatic castrate resistant prostate cancer in patients who are ineligible for therapy with 177Lu-PSMA617

2024-2028AbbVie Inc.

Kidney Cancer Research Program Clinical Consortium Duke University Clinical Trial Site Award

2024-2028Department of Defense

DoD: PCRP Clinical Consortium: Duke University Clinical Research Site

2007-2026Department of Defense

Propella: Intramuscular abiraterone decanoate for metastatic prostate cancer PRL-02

2022-2026Propella Therapeutics Inc

DCI Centers, Cancer Types & Labs

Center for Onco-Primary Care

Center for Prostate and Urologic Cancers